Skip to contentC
CNBX Pharmaceuticals Inc.
C
CNBXCNBX Pharmaceuticals Inc. Q1 2016 · 10-Q
Revenue$0.00$0.00no prior Q1 2015 on file Net Income-$147.01K-$147.01KN/M vs Q1 2015 EPS Diluted-$0.00-$0.00N/M vs Q1 2015 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
Operating Cash Flow-$146,956N/M ended Nov 30, 2016 · filed Jan 17, 2017 · 48 d after period end